|
■英文
1. |
Potential of dental mesenchymal cells
in developing teeth.
H. Yamazaki, M. Tsuneto, M. Yoshino, K. Yamamura, S-I. Hayashi. Stem
cells (in press) (2006) |
2. |
Constant rate of steady-state self-antigen trafficking
from skin to regional lymph node. M. Yoshino, H. Yamazaki, LD. Shultz,
S-I. Hayashi. Int. Immunol. 18 1541-1548 (2006) |
3. |
Presence and distribution of neural
crest-derived cells in the murine developing thymus and their potential
for differentiation.
H. Y amazaki, E. Sakata, T. Yamane, A. Yanagisawa, K. Abe, K. Yamamura,
S-I. Hayashi and T. Kunisada. Int. Immunol. 17: 549-58. (2005) |
4. |
Suppression of progressive loss of coat color in
microphthalmia-vitiligo mutant mice.
K. Kurita, M. Nishito, H. Shimogaki, K. Takada , H. Yamazaki and T.
Kunisada T. J Invest Dermatol. 125(3):538-44.(2005) |
5. |
Ascorbic acid promotes
osteoclastogenesis from embryonic stem cells. M. Tsuneto,
H. Yamazaki, M.Yoshino, T.Yamada and S-I. Hayashi. Biochem Biophys Res
Commun. 335(4):1239-46.(2005). |
6. |
Enforced expression of PU.1 rescues osteoclastogenesis
from embryonic stem cells lacking tal-1.
M. Tsuneto, A. Tominaga, H. Yamazaki, M. Yoshino, S. Orkin and S-I.
Hayashi. Stem Cell. 23:134-43. (2005) |
7. |
Cooperative and indispensable roles
of endothelin 3 and KIT signalings in melanocyte development.
H. Aoki, T. Motohashi, N. Yoshimura, H. Yamazaki, T. Yamane, J.J.
Panthier and T. Kunisada T. Dev Dyn. 233:407-17. (2005) |
8. |
Neural Crest Stem Cells and Organogenesis(Chapter VI).
In “Trends in Stem Cell Research”
Yamazaki, H., Yoshino, M., and Hayashi, S. Ed. Erik V. Greer. p147-167.
Nova Science Publisher, Inc. (2005). |
9. |
Contribution of neural crest cells in
the tooth development and the possibility of tooth regeneration.
H. Yamazaki and S-I. Hayashi. J. Oral. Biosci. 46(6): 509-518 (2004). |
10. |
Migration of dendritic cells determines divergent
immune responses.
M. Yoshino, H. Yamazaki and S-I. Hayashi. Recent Res. Develop. Biophys.
Biochem. 4: 29-48. (2004) |
11. |
Osteoclast Lineage (Chapter 27). In "
Handbook of Embryonic Stem Cells".
T. Yamane, H. Okuyama, M. Tsuneto, H. Hemmi, H. Yamazaki and S-I.
Hayashi.:, Eds. R.P. Lanza, J.D. Gearhart, B.L.M. Hogan, R.D. McKay,
D.A. Melton, R. Pedersen, J.A. Thomson, and M.D. West, Academic Press,
San Diego, CA. (2004) |
12. |
Lipopolysaccharide-induced osteoclastogenesis in Src
homology 2-domain phosphatase-1-deficient viable motheaten mice.
S. Hayashi, M. Tsuneto, T. Yamada, M. Nose, M. Yoshino, LD. Shultz and
H. Yamazaki. Endocrinology. 145(6):2721-9.(2004) |
13. |
Developmental changes of Ni (2+)
sensitivity and automaticity in Nkx2.5-positive cardiac precursor cells
from murine embryonic stem cell.
K. Manabe, J. Miake, N. Sasaki, H. Furuichi, S. Yano, E. Mizuta, Y.
Yamamoto, Y. Hoshikawa, H. Yamazaki, F. Tajima, G. Shiota, E. Nanba, S.
Ohgi, K. Hidaka, T. Morisaki, Y. Kurata, JK. Lee, O. Igawa, C.
Shigemasa and I. Hisatome. Circ J. 68(7):724-6.(2004) |
14. |
Soluble c-kit receptor mobilizes hematopoietic stem
cells to peripheral blood in mice.
Y. Nakamura, F. Tajima, K. Ishiga, H. Yamazaki, M. Oshimura, G. Shiota
and Y. Murawaki. Exp Hematol. 32(4):390-396. (2004) |
15. |
Retinoic acid receptor dominant
negative form causes steatohepatitis and liver tumor in transgenic mice.
A. Yanagitani, S. Yamada, S. Yasui, T. Shimomura, R. Murai, T.Kanbe, T.
Saeki, M. Ichiba, Y. Tanabe, S. Morino, A. Kurimasa, N. Usuda, H.
Yamazaki, T. Kunisada, H. Ito, Y. Murawaki and G. Shiota. Hepatology.
40(2):366-75. (2004) |
16. |
Tooth development and tooth regeneration using tooth
germ, dental pulp cells, neural crest cells and embryonic stem cells.
H. Yamazaki, T. Kurino, E. Sakata, M. Yoshino and S.I. Hayashi. Recent
Res. Develop. Biophys. Biochem. 3: 907-925. (2003) |
17. |
In vitro differentiation of mouse ES
cells into hematopoietic, endothelial, and osteoblastic cell lineages:
the possibility of in vitro organogenesis.
M. Tsuneto, T. Yamane, H. Okuyama, H. Yamazaki and S.I. Hayashi.
Methods Enzymol. 365:98-114. (2003) |
18. |
Generation of structures formed by lens and retinal
cells differentiating from embryonic stem cells.
M. Hirano, A. Yamamoto, N. Yoshimura, T. Tokunaga, T. Motohashi, K.
Ishizaki, H. Yoshida, K. Okazaki, H. Yamazaki, S.I. Hayashi and T.
Kunisada. Dev Dyn. 228(4):664-71. (2003) |
19. |
Discrete types of osteoclast
precursors can be generated from embryonic stem cells.
H. Okuyama, M. Tsuneto, T. Yamane, H. Yamazaki and S.I. Hayashi. Stem
cells, 21: 670-680 (2003) |
20. |
Distinct osteoclast precursors in the bone marrow and
extramedullary organs characterized by responsiveness to Toll-like
receptor ligands and TNF-a.
S.I. Hayashi, T. Yamada, M. Tsuneto, T. Yamane, M. Takahashi, L.D.
Shultz and H. Yamazaki. J. Immunol. 171: 5130-5139 (2003). |
21. |
Distinct antigen trafficking from
skin in the steady and active states.
M. Yoshino, H. Yamazaki, H. Nakano, T. Kakiuchi, K. Ryoke, T. Kunisada
and S.I. Hayashi. Int. Immunol., 15: 773-779 (2003). |
22. |
Regulation of osteoclast development by Notch signaling
directed to osteoclast precursors and through stromal cells.
T. Yamada, H. Yamazaki, T. Yamane, M. Yoshino, H. Okuyama, M. Tsuneto,
T. Kurino, S.I. Hayashi and S. Sakano. Blood, 101(6):2227-2234 (2003). |
23. |
Reduction of osteoclast in a critical
embryonic period is essential for inhibition of mouse tooth eruption.:
M. Yoshino, H. Yamazaki, H. Yoshida, S. Niida, S.I. Nishikawa, K.
Ryoke, T. Kunisada and S.I. Hayashi. J. Bone. Miner. Res., 18:108-116
(2003). |
24. |
Clonotypic analysis of T cells accumulating at
arthritic lesions in HTLV-I env-pX transgenic rats.
T. Sugaya, A. Ishizu, H. Ikeda, Y. Nakamaru, K. Fugo, M. Higuchi, H.
Yamazaki, K. Imai and T. Yoshiki, T. Exp. Mol. Pathol., 72:56-61 (2002). |
25. |
Requirement for MD-1 in cell surface
expression of RP105/CD180 and B cell responsiveness to
lipopolysaccharide.
Y. Nagai, R. Shimazu, H. Ogata, S. Akashi, K. Sudo, H. Yamazaki, S.I.
Hayashi, Y. Iwakura, M. Kimoto and K. Miyake.
Blood. 99:1699-1705 (2002). |
26. |
Development of osteoclast lineage cells.
H. Okuyama, H.Yamazaki, T. Yamane and S.I. Hayashi. Research Advances
in Blood. (Global Research Network), 1: 75-84 (2001).
|
27. |
Immunological hyperresponsiveness in
HTLV-I LTR-env-pX transgenic rats: a prototype animal model for
collagen vascular and HTLV-I-related inflammatory diseases.
Y. Nakamaru, A. Ishizu, H. Ikeda, T. Sugaya, K. Fugo, M. Higuchi, H.
Yamazaki and T. Yoshiki. Pathobiology. 69:11-18.(2001) |
28. |
Skinantigens in the steady state are trafficked to
regional lymph nodes by transforming growth factor-b1-dependent cells.
H. Hemmi, M. Yoshino, H. Yamazaki, M. Naito, T. Iyoda, Y. Omatsu, S.
Shimoyama, J.J. Letterio, T. Nakabayashi, H. Tagaya, T. Yamane, M.
Ogawa, S.I. Nishikawa, K. Ryoke, K. Inaba, S.I. Hayashi and T.
Kunisada. Int. Immunol., 13: 695-704 (2001). |
29. |
Temporal and spatial localization of
osteoclasts in colonies from embryonic stem cells.
H. Hemmi, H. Okuyama, T. Yamane, S. Nishikawa, T. Nakano, H. Yamazaki,
T. Kunisada and S. Hayashi. Biochem. Biophys. Res. Commun.,
280(2):526-534 (2001). |
30. |
Presence of osteoclast precursors in colonies cloned in
the presence of hematopoietic colony-stimulating factors.
H. Yamazaki, T. Kunisada, Y. Yamane and S. I. Hayashi. Exp. Hematol.,
29(1):68-76 (2001). |
31. |
Wnt signaling regulates hemopoiesis
through stromal cells.
T. Yamane, T. Kunisada, H. Tsukamoto, H. Yamazaki, H. Niwa, S. Takada
and S.I. Hayashi. J. Immunol., 167(2):765-772 (2001). |
32. |
Ligands for receptor tyrosine kinases expressed in the
skin as environmental factors for melanocyte development.
T. Kunisada, H. Yamazaki, and S.I. Hayashi. J. Invest. Dermatol. Symp.
Proc., 6: 6-9 (2001). |
33. |
Characterization of a novel member of
the FGFR family, HrFGFR, in Halocynthia roretzi.
S. Kamei, I. Yajima, H. Yamamoto, A. Kobayashi, K.W. Makabe, H.
Yamazaki, S.I. Hayashi and T. Kunisada. Biochem. Biophys. Res. Commun.,
275: 503-508 (2000). |
34. |
Sequential requirements for SCL/tal-1, GATA-2,
macrophage colony-stimulating factor, and osteoclast differentiation
factor/osteoprotegerin ligand in osteoclast development.
T. Yamane, T. Kunisada, H. Yamazaki, T. Nakano, S. H. Orkin and S.I
Hayashi. Exp. Hematol., 28(7):833-840 (2000). |
35. |
Keratinocyte expression of transgenic
hepatocyte growth factor affects melanocyte development, leading to
dermal melanocytosis.
T. Kunisada, H. Yamazaki, T. Hirobe, S. Kamei, M. Omoteno, H. Tagaya,
H. Hemmi, U. Koshimizu, T. Nakamura and S.I. Hayashi. Mech. Dev., 94:
67-78 (2000). |
36. |
Intramedullary and extramedullary B lymphopoiesis in
osteopetrotic mice.
H. Tagaya, T. Kunisada, H. Yamazaki, T. Yamane, T. Tokuhisa, E.F.
Wagner, T. Sudo, L.D. Shultz and S.I. Hayashi. Blood, 95(11):3363-3370
(2000). |
37. |
Accelerated growth of hepatocytes in
association with Up-regulation of cyclin E in transgenic mice
expressing the dominant negative form of retinoic acid receptor. A.
Tsutsumi, G. Shiota,
H. Yamazaki, T. Kunisada, T. Terada and H. Kawasaki. Biochem. Biophys.
Res. Commun., 278: 229-235 (2000). |
38. |
Derivation of melanocytes from embryonic stem cells in
culture. T. Yamane, S.I. Hayashi, M. Mizoguchi, H. Yamazaki and T.
Kunisada. Dev. Dyn., 216 :450-458 (1999). |
39. |
Tooth-specific expression conferred
by the regulatory sequences of rat dentin sialoprotein gene in
transgenic mice. H.Yamazaki, T. Kunisada, A. Miyamoto, H. Tagaya and
S.I. Hayashi.
Biochem. Biophys. Res. Commun., 260: 433-440 (1999). |
40. |
CD9 molecule expressed on stromal cells is involved in
osteoclastogenesis. Y. Tanio, H. Yamazaki, T. Kunisada, K. Miyake and
S.I. Hayashi. Exp. Hematol., 27: 853-859 (1999). |
41. |
Transgene expression of steel factor
in the basal layer of epidermis promotes
survival, proliferation, differentiation and migration of melanocyte
precursors.
T. Kunisada, H. Yoshida, H. Yamazaki, A. Miyamoto, H. Hemmi, E.
Nishimura, L.D. Shultz, S.I. Nishikawa and S.I. Hayashi. Development,
125: 2915-2923. (1998). |
42. |
Establishment and characterization of an immortal
macrophage-like cell line inducible
to differentiate to osteoclasts. A. Miyamoto, T. Kunisada, H. Hemmi, T.
Yamane, H. Yasuda, K. Miyake, H. Yamazaki and S.I. Hayashi. Biochem.
Biophys. Res. Commun., 242: 703-709 (1998). |
43. |
Promotion of early osteoclastogenesis
and B lymphopoiesis in the bone marrow
of transgenic rats with the env-pX gene of human T-cell lymphotropic
virus type I.
H.Yamazaki, T. Kunisada, A. Ishizu, H. Ikeda, I. Miyoshi, T. Sudo, S.I.
Hayashi and T. Yoshiki. Oncogene, 17: 2955-2960 (1998). |
44. |
Commitment and differentiation of stem cells to the
osteoclast lineage. S.I. Hayashi, T. Yamane, A. Miyamoto, H. Hemmi, H.
Tagaya, Y. Tanio, H. Kanda, H. Yamazaki and
T. Kunisada. Biochem. Cell Biol., 76: 911-922 (1998). |
45. |
Establishment and characterization of
pro-B cell lines from motheaten mutant mouse defective in SHP-1 protein
tyrosine phosphatase. A. Miyamoto, T. Kunisada, H. Yamazaki, K. Miyake,
S.I. Nishikawa, T. Sudo, L.D. Shultz and S.I. Hayashi.
Immunol. Let., 63: 75-82 (1998). |
46. |
HTLV-I env-pX transgenic rats: prototype animal model
for collagen vascular diseases.
H. Yamazaki, H. Ikeda, A. Ishuzu, H. Shikishima, K. Kikuchi, A.
Wakisaka, M. Hatanaka and T. Yoshiki. Leukemia. 11: Suppl 3: 258-259
(1997). |
47. |
Development of osteoclasts from
embryonic stem cells through a pathway that is c-fms, but not c-kit
dependent. T. Yamane, T. Kunisada, H. Yamazaki, T. Era, T. Nakano and
S.I. Hayashi. Blood, 90: 3516-3523 (1997). |
48. |
Osteoclast precursors in bone marrow and peritoneal
cavity. S.I. Hayashi, A. Miyamoto, T. Yamane, H. Kataoka, M. Ogawa, S.
Sugawara, S. Nishikawa, S.I. Nishikawa, T. Sudo, H. Yamazaki and T.
Kunisada. J. Cell. Physiol., 170: 241-247 (1997). |
49. |
A wide spectrum of collagen vascular
and autoimmune diseases in transgenic rats carrying
the env-pX gene of human T-lymphotropic virus type I. H. Yamazaki, H.
Ikeda, A. Ishizu, Y. Nakamaru, T. Sugaya, K. Kikuchi, S. Yamada, A.
Wakisaka, N. Kasai, T. Koike, M. Hatanaka and T. Yoshiki. Int.immunol.,
9:339-346 (1997). |
50. |
HTLV-I pX transgenic rats:development of
cytokine-producing mammary carcinomas and establishment of the pX
mammary carcinoma cell lines. H. Shikishima, H. Ikeda, S. Yamada, H.
Yamazaki, K. Kikuchi, A. Wakisaka, N. Kasai, K, Shimotohno and T.
Yoshiki. Leukemia.11: Suppl 3:70-72 (1997). |
51. |
Models of HTLV-I-induced
diseases.Infectious transmission of of HTLV-I in inbred rats andHTVL-I
env-pX transgenic rats. T. Yoshiki, H. Ikeda, U. Tomaru, N. Kasai, S.
Ohya, T. Kasai, I. Yamashita, K. Morita, H. Yamazaki, A. Ishizu, Y.
Nakamaru, K. Kikuchi, S. Tanaka and A. Wakisaka. Leukemia.11: Suppl
3:245-246 (1997). |
52. |
Progressive effects of α-phenyl-N-tert-butyl nitrone
(PBN) on rat embryo development in vitro. T. Yamashita, H.Yamazaki, Y.
Kon, T. Watanabe, J. Arikawa, I. Miyoshi, N. Kasai and M. Kuwabara.
Free Rad. Biol. Med., 23: 1073-1077 (1997). |
53. |
Cytokine-producing mammary carcinoma
in transgenic rats carrying the pX gene of
human T-lymphotropic virus type I. S. Yamada, H. Ikeda, H. Yamazaki, H.
Shikishima, K.
Kikuchi, A. Wakisaka, N. Kasai, K. Shimotohno and T. Yoshiki.
Cancer Res., 55: 2524-2527 (1995).
|
■和文
1. |
蟯虫とヒト急性虫垂炎との関係について
clinical parasitology Vol5 No.1 59-62 (1994)
河合薫子、山崎英俊、石倉 浩、八木欣平、佐藤昇志、高橋秀史、菊池浩吉、石倉 肇
|
2. |
Development of collagen vascular diseases and
production of autoantibodies in HTLV-I env-pX transgenic rats.
山崎英俊 北海道医学学会誌71: 325-343 (1996).
|
3. |
SCFトランスジェニックマウス血液・腫瘍科36(4):p338-345.(1998)
邊見弘明、山崎英俊、林 眞一、国貞隆弘
|
4. |
HTLV-I
env-pXトランスジェニックラットにおける破骨細胞及びB細胞系譜への影響第38回日本リンパ網内系学会誌 Vol.38 .p203-209
(1998). 山崎英俊、宮本顕友、池田 仁、石津明洋、国貞隆弘、林 眞一、吉木 敬
|
5. |
HTLV-I 遺伝子導入モデル動物を用いたHTLV-I関連疾患発症機構の解明
上原記念生命科学財団研究報告集Vol.12 p328-331.(1998). 山崎英俊
|
6. |
破骨細胞分化とストローマ細胞: 蛋白核酸酵素Vol 44, No.7.p854-864.(1999).
山崎英俊、林眞一
|
7. |
再生医療をめざした胚性幹(ES)細胞試験管内分化誘導 Jpn. J.
Leprosy Vol70p121-126. (2001) 林眞一、山根利之、奥山洋美、山崎英俊
|
8. |
ES細胞からの試験管内分化と器官形成.ホルモンと臨床 Vol.51, No.2 p99-103
(2003).林眞一、奥山洋美、経遠智一、山崎英俊
|
9. |
神経堤細胞と器官形成 鶴見大学歯学部顎機能研究センター 第二回公開シンポジウ
ムプロシーデイング 別刷:95-97.(2003). 山崎英俊
|
10. |
ES細胞から心筋細胞への分化の分子機序:分子心血管病 5:p263-271.
(2004) 三明淳一郎、山崎英俊、久留一郎
|
■著書
1. |
著書(共著)
免疫学コア講義(分担執筆)免疫関連細胞:山崎英俊、林 眞一、木本雅夫:p15-28 木本雅夫、坂口薫雄、山下優毅 編集 南山堂 (2002)
|
|
|